Does ADALIMUMAB Cause Injection site discharge? 691 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 691 reports of Injection site discharge have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.1% of all adverse event reports for ADALIMUMAB.
691
Reports of Injection site discharge with ADALIMUMAB
0.1%
of all ADALIMUMAB reports
0
Deaths
28
Hospitalizations
How Dangerous Is Injection site discharge From ADALIMUMAB?
Of the 691 reports, 28 (4.1%) required hospitalization.
Is Injection site discharge Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 691 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Injection site discharge?
TREPROSTINIL (463)
SEMAGLUTIDE (388)
SOMATROPIN (283)
DUPILUMAB (130)
FREMANEZUMAB-VFRM (117)
EXENATIDE (110)
RISANKIZUMAB-RZAA (107)
CORTICOTROPIN (98)
VEDOLIZUMAB (87)
HUMAN IMMUNOGLOBULIN G (85)
Which ADALIMUMAB Alternatives Have Lower Injection site discharge Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB